To require the Food and Drug Administration to issue a monograph with respect to over-the-counter sunscreen.

1. Inserts new text on page 173, line 24

   InsertsPrinted page

   Inserted: Sec. 7 . (a) Congress makes the following findings:

   Inserted: (1) Consumers need clear and consistent information about the risks associated with exposure to the sun, and the protection offered by over-the-counter sunscreen products.

   Inserted: (2) The Food and Drug Administration (referred to in this section as the "FDA") began developing a monograph for over-the-counter sunscreen products in 1978.

   Inserted: (3) In 2002, after 23 years, the FDA issued the final monograph for such sunscreen products.

   Inserted: (4) One of the most critical aspects of sunscreen is how to measure protection against UVA rays, which cause skin cancer.

   Inserted: (5) The final sunscreen monograph failed to address this critical aspect and, accordingly, the monograph was stayed shortly after being issued until issuance of a comprehensive monograph.

   Inserted: (6) Skin cancer rates continue to rise, especially in younger adults and women.

   Inserted: (7) Pursuant to section 751 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379r), a Federal rule on sunscreen labeling would preempt any related State labeling requirements.

   Inserted: (8) The absence of a Federal rule could lead to a patchwork of State labeling requirements that would be confusing to consumers and unnecessarily burdensome to manufacturers.

   Inserted: (b) Not later than one year after the date of enactment of this Act, the FDA shall issue a comprehensive final monograph for over-the-counter sunscreen products, which shall include UVA and UVB labeling requirements.

   Original wording

   On page 173, after line 24, insert the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed